troxacitabine has been researched along with Adenocarcinoma Of Kidney in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Belanger, K; Bjarnason, GA; Chi, K; Ernst, DS; Goel, R; Jolivet, J; McIntosh, L; Moore, MJ; Ruether, JD; Seymour, L; Siu, LL; Stewart, D; Tannock, I; Townsley, CA | 1 |
Angers, EG; Attardo, G; Bednarski, K; Bibeau, L; Bowlin, TL; Cimpoia, A; DeMuys, JM; Kadhim, SA; Waud, WR | 1 |
1 trial(s) available for troxacitabine and Adenocarcinoma Of Kidney
Article | Year |
---|---|
Phase II study of troxacitabine (BCH-4556) in patients with advanced and/or metastatic renal cell carcinoma: a trial of the National Cancer Institute of Canada-Clinical Trials Group.
Topics: Aged; Antineoplastic Agents; Canada; Carcinoma, Renal Cell; Cytosine; Dioxolanes; Disease Progression; Drug Administration Schedule; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Treatment Outcome | 2003 |
1 other study(ies) available for troxacitabine and Adenocarcinoma Of Kidney
Article | Year |
---|---|
Potent antitumor activity of a novel nucleoside analogue, BCH-4556 (beta-L-dioxolane-cytidine), in human renal cell carcinoma xenograft tumor models.
Topics: Animals; Antineoplastic Agents; Carcinoma, Renal Cell; Cytosine; Dioxolanes; Drug Screening Assays, Antitumor; Female; Humans; Kidney Neoplasms; Mice; Neoplasm Transplantation; Nucleosides; Transplantation, Heterologous; Tumor Cells, Cultured | 1997 |